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HIV Counseling and Testing Data System
Testing in the United States
Human immunodeficiency virus (HIV) testing is available
in many settings in the United States. Voluntary testing
can be obtained in medical care settings such as physician
offices, hospitals, managed care organizations, and public
clinics and through home-collection kits (Food and Drug
Administration, 1996). Other extensive screening programs,
with different motives for offering or requiring testing,
test military personnel, blood donors, correctional institution
inmates, and insurance applicants. The U.S. military
performs approximately 1.1 million tests per year, as part
of routine medical examinations, on all applicants and
active-duty soldiers (Brown & Burke, 1995). Eight million
persons make 12 million blood donations each year and
are tested for HIV at each donation (Lackritz et al., 1995).
In addition, persons who donate or sell plasma are tested
at the time of each donation. Although precise data on the
total number of tests performed annually in the United
States are unavailable, several surveys have found that
one-third of adults have been tested for HIV, including
those tested through blood donation (Schoenborn, Marsh,
& Hardy, 1994). In the 1992 National Health Interview
Survey, 9% of adult respondents indicated that they had
been tested for HIV during the preceding 12 months in
settings other than those for blood donation. This suggests
that, including persons tested during blood donation,
approximately 24.6 million persons are tested in the United
States during a 12-month period (Weber, Frey, Horsley, &
Gwinn, 1997).
Publicly Funded Testing
Publicly funded counseling and HIV antibody testing
services (i.e., services provided by state and local health
departments with Centers for Disease Control and
Prevention [CDC] funding) were initiated in March 1985
to provide an alternative to blood donation as a means for
high-risk persons to determine their HIV status. Counseling
was considered essential to address the accuracy and the
consequences of the test and was designed to help persons
understand the meaning of positive or negative antibody
test results. HIV tests funded by CDC are routinely offered
with pre- and posttest counseling. In 1987, emphasis was
placed on risk-reduction counseling (CDC, 1987; Rugg,
MacGowan, Stark, & Swanson, 1991). Since then,
standards and guidelines for counseling, testing, and referral
have been revised to promote a client-centered model
(CDC, 1994). These services became an integral part of
HIV prevention programs, and the HIV Counseling and
Testing System was developed to monitor them (see
Technical Notes).
The figures and tables in this report are based on data and
corrections sent to CDC through June 30, 1997. Tables 1-
9 comprise data collected from January through December
1996. The record format for each reporting area is
indicated in Table 6.
Overview, 1989-1996
The number of persons receiving HIV counseling and
testing (CT) services at publicly funded sites increased
markedly between 1989 and 1992. Since 1992, the number
of tests has remained relatively stable; 2,623,873 tests
were performed in 1996 (Figure 1).  The number of HIV-
positive test results peaked at 57,879 in 1991 and decreased
to 39,119 in 1996 (Figure 2). As a proportion of all test
results, HIV-positive test results declined from 4.4% in
1989 to 1.5% in 1996. Similar trends were observed for
most well-defined groups and sites that have more than
50,000 tests annually, including men and women, racial/
ethnic groups, testing sites, age groups, and risk/exposure
groups.  These findings are consistent with the observation
that persons being tested are increasingly likely to have
been tested previously and that those found to be HIV-
positive tend not to seek repeat testing. The manner in
which these data are collected does not allow analysis
that would determine whether this decline reflects a true
decline in the prevalence or the incidence of HIV infection.
A few groups had small increases in the percentage of
test results that were positive: prenatal/obstetric sites,
uncategorized (other) health department sites, and the
offices of private medical doctors. The increase at each
of these sites was 0.1% between 1995 and 1996.
HIV Counseling and Testing Sites
The proportion of all tests performed in freestanding HIV
CT sites declined from 36.8% in 1989 to 28.4% in 1996.
Although freestanding CT sites continued to report the
largest proportion of HIV-positive test results, this
proportion declined from 48.6% in 1989 to 32.5% in 1996.
Sexually transmitted disease (STD) clinics reported 26.3%
of all tests (Figure 3) and 25.0% of HIV-positive test
results in 1996 (Figure 4).
Drug treatment facilities and prisons accounted for a small
proportion of all tests; however, a high proportion of test
results at these sites were HIV-positive (2.6%, Table 1).
The only site type with a higher percentage of positive
test results was private MD/clinics (Table 1), where clients
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The number of tests reported by the number, type of risk,
and positive result are shown in Table 3a (males) and
3b (females).
In 1996, the sole risk reported most often by men was
heterosexual exposure (75%).  The two risks most
commonly reported together by men were heterosexual
exposure and history of an STD (16%). The three risks
most commonly reported together by men were
heterosexual exposure, history of an STD, and having a
sex partner at risk for HIV (7%). In each grouping of
single or multiple risks, the highest percentage of positive
test results was for men who reported a sex partner with
HIV or acquired immunodeficiency syndrome (AIDS) as
one of the risks (8.5%-12.5%). These findings are similar
to 1995 data (see Erratum and Appendix).
In 1996, the sole risk reported most often by women was
heterosexual exposure (86%). The two risks most
commonly reported together by women were heterosexual
exposure and having a sex partner at risk for HIV (26%).
The three risks most commonly reported together by
women were heterosexual exposure, history of an STD,
and having a sex partner at risk for HIV (13%). In each
grouping of single or multiple risks, the highest percentage
of positive test results was for women who reported a
sex partner with HIV or AIDS as one of the risks
(5.4%-16.5%).
Posttest Counseling
The proportion of tests reported with posttest counseling
increased from 38.9% in 1989 to 61.3% in 1996. More of
the tests performed at freestanding HIV CT sites were
reported with posttest counseling (81.7%, Table 4a). The
complement of these numbers does not represent persons
who did not get posttest counseling; it represents tests
with posttest counseling reported as no and those for
which posttest counseling information was missing.
The proportion of tests with posttest counseling differed
by project area. Client record data indicate that 12 of the
44 project areas had posttest counseling rates of more
than 80%; 6 of the 44 project areas had rates of less than
50% (Table 8). This large difference can be attributed to
other factors in addition to clients not returning, including
project area data systems that do not collect complete
posttest counseling data and project areas not reporting
posttest counseling data. There is a higher percentage of
positive test results than negative test results that have
posttest counseling reported (74.4% vs. 66.9%) (Table
9). This difference is likely caused by outreach efforts by
project areas among persons who test positive.
may be more likely to attend and be tested when symptoms
develop that are suggestive of HIV infection.
In family planning and prenatal/obstetric clinics, only 0.2%
and 0.8% of all test results, respectively, were HIV-
positive; nonetheless, these sites together reported 2,458
HIV-positive test results for women (6.3% of all positive
tests reported). This percentage has increased
substantially since 1994, particularly in prenatal/obstetric
clinics, where the number of tests increased from 142,394
in 1994, to 159,874 in 1995 (12% increase) and to 211,552
in 1996 (32% increase). Positive test results in prenatal/
obstetric clinics increased from 632 in 1994 to 1,100 in
1995 (74% increase) and to 1,598 in 1996 (45% increase).
This dramatic increase in testing is probably in response
to recommendations for voluntary testing of pregnant
women and treatment of infected women with
antiretroviral therapy to prevent the perinatal transmission
of HIV (CDC, 1995).
Demographic Groups
More than half of all HIV tests at publicly funded sites in
1996 were performed on women, although more than two-
thirds of HIV-positive test results were for men (Table
1). For both men and women, the largest proportion of all
HIV tests were performed on persons 20 to 29 years of
age; the largest proportion of HIV-positive test results
were for persons 30 to 39 years of age (Figures 5 and 6).
Among adolescents aged 13 to 19, more females than
males were tested and more females were HIV-positive,
although the percentage of positive test results was higher
among men (0.4%) than among women (0.2%)
(Table 2).
In 1996, fewer than half of all HIV tests were performed
on black  or Hispanic persons, but these groups accounted
for more than two-thirds of all HIV-positive test results
(Figures 7 and 8).
Risk Exposure Groups
For typical analysis and reporting purposes, a single risk
behavior (except for the combination of a man who has
sex with men and uses injection drugs) is assigned for
each testing episode by using a standard hierarchy (see
Technical Notes). According to this hierarchy, in 1996,
persons with reported history of male-male sex or
injection drug use accounted for 13.0% of all tests, but
for 47.7% of all HIV-positive test results (Figures 9 and
10). Fewer than half of tests were performed on persons
with only one reported risk.
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*Includes TB, college, and private MD/clinic sites.
Figure 4. HIV-positive tests by site type, publicly funded sites, 1996
U.S. total
Percent of HIV-positive tests
N = 39,119
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Figure 5. HIV tests by age and sex, publicly funded sites, 1996
U.S. total
Source: Centers for Disease Control and Prevention
Figure 6. HIV-positive tests by age and sex, publicly funded sites, 1996
U.S. total











































































Figure 7. HIV tests by race/ethnicity, publicly funded sites, 1996
Percent of tests
N = 2,579,018
Figure 8. HIV-positive tests by race/ethnicity, publicly funded sites, 1996
U.S. total
Percent of HIV-positive tests
N = 38,304
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Source: Centers for Disease Control and Prevention
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Figure 10. HIV-positive tests by risk exposure, publicly funded sites, 1996
Client Record Data
Percent of HIV-positive tests
N = 35,590
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Table 1. HIV tests by demographic group, risk exposure, and site type,
publicly funded sites, 1996
U.S. total
Positive Percent of Percent of
   No. of tests             No.       (%) total tests    total positive
Male 1,113,384 26,382 (2.4) (43.2) (68.9)
Female 1,465,634 11,922 (0.8) (56.8) (31.1)
Total 2,579,018 38,304 (1.5) (100.0) (100.0)
White 1,232,126 10,191 (0.8) (47.8) (26.6)
Black 824,133 19,223 (2.3) (32.0) (50.2)
Hispanic 400,364 7,753 (1.9) (15.5) (20.2)
Asian/Pacific Islander 44,074 246 (0.6) (1.7) (0.6)
American Indian/Alaska Native 15,062 162 (1.1) (0.6) (0.4)
Undetermined 63,259 729 (1.2) (2.5) (1.9)
Total 2,579,018 38,304 (1.5) (100.0) (100.0)
<5 3,517 124 (3.5) (0.1) (0.3)
  5-12 6,055 46 (0.8) (0.2) (0.1)
13-19 468,838 1,258 (0.3) (18.2) (3.3)
20-29 1,048,802 10,590 (1.0) (40.7) (27.6)
30-39 644,010 16,342 (2.5) (25.0) (42.7)
40-49 289,665 7,702 (2.7) (11.2) (20.1)
>= 50 111,330 2,147 (1.9) (4.3) (5.6)
Unknown 6,801 95 (1.4) (0.3) (0.2)
Total 2,579,018 38,304 (1.5) (100.0) (100.0)
Homosexual/bisexual IDU 11,957 1,130 (9.5) (0.5) (2.9)
Homosexual/bisexual 157,776 10,389 (6.6) (6.0) (26.6)
Heterosexual IDU 140,481 6,381 (4.5) (5.4) (16.3)
Hemophilia 119 6 (5.0) (0.0) (0.0)
Blood recipient 16,822 231 (1.4) (0.6) (0.6)
Heterosexual at risk 1,018,357 11,797 (1.2) (38.8) (30.2)
Other 986,548 6,113 (0.6) (37.6) (15.6)
Unknown 292,152 3,068 (1.1) (11.1) (7.8)
Total 2,624,212 39,115 (1.5) (100.0) (100.0)
HIV CTS 745,914 12,707 (1.7) (28.4) (32.5)
STD 691,287 9,781 (1.4) (26.3) (25.0)
Drug treatment 111,309 2,878 (2.6) (4.2) (7.4)
Family planning 351,279 860 (0.2) (13.4) (2.2)
Prenatal/OB 211,552 1,598 (0.8) (8.1) (4.1)
TB 27,580 426 (1.5) (1.1) (1.1)
Other health department 182,024 3,533 (1.9) (6.9) (9.0)
Prison 106,745 2,791 (2.6) (4.1) (7.1)
College 1,523 1 (0.1) (0.1) (0.0)
Private MD/clinic 36,482 1,179 (3.2) (1.4) (3.0)
Other 154,857 3,305 (2.1) (5.9) (8.4)
Unknown 3,321 60 (1.8) (0.1) (0.2)
Total 2,623,873 39,119 (1.5) (100.0) (100.0)
Note: Several areas do not report all variables on each test (i.e., risk factors, sex, age, and race/ethnicity);
therefore, the totals in sections of the tables may differ.
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Table 2. HIV tests by age group, race/ethnicity, and sex, publicly funded sites, 1996
U.S. total
Note: Only includes tests with sex specified.
< 5
White 456 7 (1.5) 536 9 (1.7) 992 16 (1.6)
Black 732 38 (5.2) 809 36 (4.4) 1,541 74 (4.8)
Hispanic 331 16 (4.8) 387 10 (2.6) 718 26 (3.6)
Asian/Pacific Islander 15 0 (0.0) 25 1 (4.0) 40 1 (2.5)
American Indian/Alaska Native 9 0 (0.0) 10 0 (0.0) 19 0 (0.0)
Undetermined 101 4 (4.0) 106 3 (2.8) 207 7 (3.4)
Tota l 1,644 65 (4.0) 1,873 59 (3.2) 3,517 124 (3.5)
5-12
White 945 4 (0.4) 1,248 5 (0.4) 2,193 9 (0.4)
Black 949 12 (1.3) 1,381 15 (1.1) 2,330 27 (1.2)
Hispanic 540 6 (1.1) 608 4 (0.7) 1,148 10 (0.9)
Asian/Pacific Islander 44 0 (0.0) 53 0 (0.0) 97 0 (0.0)
American Indian/Alaska Native 33 0 (0.0) 24 0 (0.0) 57 0 (0.0)
Undetermined 118 0 (0.0) 112 0 (0.0) 230 0 (0.0)
Total 2,629 22 (0.8) 3,426 24 (0.7) 6,055 46 (0.8)
13-19
White 56,489 90 (0.2) 167,631 146 (0.1) 224,120 236 (0.1)
Black 46,899 258 (0.6) 105,444 505 (0.5) 152,343 763 (0.5)
Hispanic 23,855 106 (0.4) 47,559 116 (0.2) 71,414 222 (0.3)
Asian/Pacific Islander 2,139 5 (0.2) 4,842 1 (0.0) 6,981 6 (0.1)
American Indian/Alaska Native 1,010 2 (0.2) 1,961 2 (0.1) 2,971 4 (0.1)
Undetermined 3,340 14 (0.4) 7,669 13 (0.2) 11,009 27 (0.2)
Tota l 133,732 475 (0.4) 335,106 783 (0.2) 468,838 1,258 (0.3)
20-29
White 198,099 2,247 (1.1) 294,195 717 (0.2) 492,294 2,964 (0.6)
Black 133,121 2,814 (2.1) 191,341 2,265 (1.2) 324,462 5,079 (1.6)
Hispanic 70,324 1,510 (2.1) 107,280 697 (0.6) 177,604 2,207 (1.2)
Asian/Pacific Islander 9,064 88 (1.0) 13,390 30 (0.2) 22,454 118 (0.5)
American Indian/Alaska Native 2,348 32 (1.4) 3,087 14 (0.5) 5,435 46 (0.8)
Undetermined 11,114 132 (1.2) 15,439 44 (0.3) 26,553 176 (0.7)
Tota l 424,070 6,823 (1.6) 624,732 3,767 (0.6) 1,048,802 10,590 (1.0)
30-39
White 151,651 3,745 (2.5) 147,215 811 (0.6) 298,866 4,556 (1.5)
Black 106,845 5,025 (4.7) 112,303 2,876 (2.6) 219,148 7,901 (3.6)
Hispanic 44,556 2,373 (5.3) 53,077 1,026 (1.9) 97,633 3,399 (3.5)
Asian/Pacific Islander 4,578 67 (1.5) 4,969 16 (0.3) 9,547 83 (0.9)
American Indian/Alaska Native 1,972 64 (3.2) 2,037 17 (0.8) 4,009 81 (2.0)
Undetermined 7,516 238 (3.2) 7,291 84 (1.2) 14,807 322 (2.2)
Tota l 317,118 11,512 (3.6) 326,892 4,830 (1.5) 644,010 16,342 (2.5)
40-49
White 82,288 1,533 (1.9) 67,865 347 (0.5) 150,153 1,880 (1.3)
Black 54,284 3,068 (5.7) 37,786 1,153 (3.1) 92,070 4,221 (4.6)
Hispanic 18,621 1,065 (5.7) 17,425 358 (2.1) 36,046 1,423 (3.9)
Asian/Pacific Islander 1,728 21 (1.2) 1,624 7 (0.4) 3,352 28 (0.8)
American Indian/Alaska Native 988 13 (1.3) 922 12 (1.3) 1,910 25 (1.3)
Undetermined 3,557 94 (2.6) 2,577 31 (1.2) 6,134 125 (2.0)
Tota l 161,466 5,794 (3.6) 128,199 1,908 (1.5) 289,665 7,702 (2.7)
>=50
White 37,881 438 (1.2) 22,532 71 (0.3) 60,413 509 (0.8)
Black 20,466 830 (4.1) 10,463 289 (2.8) 30,929 1,119 (3.6)
Hispanic 8,611 306 (3.6) 6,511 143 (2.2) 15,122 449 (3.0)
Asian/Pacific Islander 877 6 (0.7) 639 4 (0.6) 1,516 10 (0.7)
American Indian/Alaska Native 343 5 (1.5) 246 1 (0.4) 589 6 (1.0)
Undetermined 1,679 42 (2.5) 1,082 12 (1.1) 2,761 54 (2.0)
Tota l 69,857 1,627 (2.3) 41,473 520 (1.3) 111,330 2,147 (1.9)
Unknown
White 1,246 16 (1.3) 1,849 5 (0.3) 3,095 21 (0.7)
Black 599 25 (4.2) 711 14 (2.0) 1,310 39 (3.0)
Hispanic 267 9 (3.4) 412 8 (1.9) 679 17 (2.5)
Asian/Pacific Islander 22 0 (0.0) 65 0 (0.0) 87 0 (0.0)
American Indian/Alaska Native 27 0 (0.0) 45 0 (0.0) 72 0 (0.0)
Undetermined 707 14 (2.0) 851 4 (0.5) 1,558 18 (1.2)
Tota l 2,868 64 (2.2) 3,933 31 (0.8) 6,801 95 (1.4)
All
White 529,055 8,080 (1.5) 703,071 2,111 (0.3) 1,232,126 10,191 (0.8)
Black 363,895 12,070 (3.3) 460,238 7,153 (1.6) 824,133 19,223 (2.3)
Hispanic 167,105 5,391 (3.2) 233,259 2,362 (1.0) 400,364 7,753 (1.9)
Asian/Pacific Islander 18,467 187 (1.0) 25,607 59 (0.2) 44,074 246 (0.6)
American Indian/Alaska Native 6,730 116 (1.7) 8,332 46 (0.6) 15,062 162 (1.1)
Undetermined 28,132 538 (1.9) 35,127 191 (0.5) 63,259 729 (1.2)
Tota l 1,113,384 26,382 (2.4) 1,465,634 11,922 (0.8) 2,579,018 38,304 (1.5)
Male Female Total
No. of Positive tests No. of Positive tests No. of Positive tests
tests No. (%) tests No. (%) tests No. (%)
MSM
Others with one risk
Total with one risk
Other combinations of two risks
Total with two risks
Other combinations of three risks





















































Table 3a. HIV tests and positive results by single and multiple exposure














































































Other combinations of four risks
Total with four risks
Risk combinations shown are limited to risks with at least 100 tests. Only 5 of the 13 risk categories are shown. "Other combinations" include combinations
of any of the 13 risk categories.
Risk categories not shown include: child of woman with HIV/AIDS, sex for drugs/money, sex while using non-injection drugs, hemophilia/blood recipient,
victim of sexual assault, health care exposure, and other.
*Includes sex partner of IDU, sex partner of MSM, sex partner of person with other HIV/AIDS risk.
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IDU
Others with one risk
Total with one risk
Other combinations of two risks
Total with two risks
Other combinations of three risks
Total with three risks
Other combinations of four risks
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Risk combinations shown are limited to risks with at least 100 tests. Only 5 of the 13 risk categories are shown. "Other combinations" include combinations
of any of the 13 risk categories.
Risk categories not shown include: child of woman with HIV/AIDS, sex for drugs/money, sex while using non-injection drugs, hemophilia/blood recipient,
victim of sexual assault, health care exposure, and other.
*Includes sex partner of IDU, sex partner of MSM, sex partner of person with other HIV/AIDS risk.
Table 3b. HIV tests and positive results by single and multiple exposure







Table 4a. HIV tests and posttest counseling sessions by site type,
publicly funded sites, 1996
U.S. total
Posttest counseling sessions*
Site type  No. of tests                 No.     (%)
*Posttest counseling indicates that persons received test results as well as counseling after testing.
HIV CTS 745,914 609,410 (81.7)
STD 691,287 317,249 (45.9)
Drug treatment 111,309 76,575 (68.8)
Family planning 351,279 167,030 (47.5)
Prenatal/OB 211,552 119,429 (56.5)
TB 27,580 12,499 (45.3)
Other health department 182,024 115,769 (63.6)
Prison 106,745 73,360 (68.7)
College 1,523 749 (49.2)
Private MD/clinic 36,482 16,190 (44.4)
Other 154,857 97,981 (63.3)
Unknown 3,321 1,738 (52.3)
Total 2,623,873 1,607,979 (61.3)
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Table 4b(1). HIV tests and posttest counseling by result for demographic group and
risk exposure, publicly funded sites, 1996
Client Record Data
Male 24,203 18,333 (75.7) 945,305 651,478 (68.9) 976,170 672,445 (68.9)
Female 10,923 8,045 (73.7) 1,191,547 783,563 (65.8) 1,215,262 796,198 (65.5)
Not specified 464 87 (18.8) 14,817 7,806 (52.7) 15,362 7,921 (51.6)
Total 35,590 26,465 (74.4) 2,151,669 1,442,847 (67.1) 2,206,794 1,476,564 (66.9)
White 9,166 7,286 (79.5) 1,030,086 774,925 (75.2) 1,045,675 785,468 (75.1)
Black 17,016 12,225 (71.8) 639,825 328,103 (51.3) 664,009 342,246 (51.5)
Hispanic 7,705 6,143 (79.7) 379,495 272,815 (71.9) 392,454 280,758 (71.5)
Asian/Pacific Islander 213 175 (82.2) 34,165 26,987 (79.0) 34,689 27,312  (78.7)
American Indian/Alaska Native 143 114 (79.7) 11,966 7,388 (61.7) 12,169 7,528 (61.9)
Other 365 284 (77.8) 24,372 18,429 (75.6) 24,918 18,780 (75.4)
Undetermined 319 111 (34.8) 17,976 5,734 (31.9) 18,367 5,853 (31.9)
Not specified 663 127 (19.2) 13,784 8,466 (61.4) 14,513 8,619 (59.4)
Total 35,590 26,465 (74.4) 2,151,669 1,442,847 (67.1) 2,206,794 1,476,564 (66.9)
<5 93 76 (81.7) 2,377 1,631 (68.6) 2,517 1,731 (68.8)
  5-12 43 36 (83.7) 4,968 3,012 (60.6) 5,055 3,066 (60.7)
13-19 1,190 825 (69.3) 381,411 228,219 (59.8) 386,301 230,308 (59.6)
20-29 9,683 7,142 (73.8) 872,186 579,624 (66.5) 890,109 589,768 (66.3)
30-39 15,271 11,402 (74.7) 542,626 377,690 (69.6) 562,711 390,920 (69.5)
40-49 7,193 5,385 (74.9) 246,045 178,970 (72.7) 255,156 185,117 (72.6)
>= 50 1,996 1,536 (77.0) 95,280 70,764 (74.3) 98,021 72,645 (74.1)
Unknown 117 59 (50.4) 6,625 2,831 (42.7) 6,761 2,898 (42.9)
Not specified 4 4 (100.0) 151 106 (70.2) 163 111 (68.1)
Total 35,590 26,465 (74.4) 2,151,669 1,442,847 (67.1) 2,206,794 1,476,564 (66.9)
MSM IDU 1,064 813 (76.4) 10,097 7,831 (77.6) 11,245 8,678 (77.2)
MSM 9,667 7,702 (79.7) 134,598 114,254 (84.9) 145,195 122,384 (84.3)
Heterosexual IDU 6,219 4,622 (74.3) 123,849 89,258 (72.1) 131,212 94,385 (71.9)
Sex partner at risk 6,737 5,268 (78.2) 449,001 339,127 (75.5) 458,954 345,967 (75.4)
Child of HIV+ woman 143 119 (83.2) 1,712 1,273 (74.4) 1,900 1,415 (74.5)
STD diagnosis 2,255 1,575 (69.8) 218,690 121,516 (55.6) 222,973 123,626 (55.4)
Sex for drugs/money 458 301 (65.7) 23,645 15,670 (66.3) 24,261 16,019 (66.0)
Sex and using drugs 938 696 (74.2) 170,760 124,016 (72.6) 172,865 125,194 (72.4)
Hemophilia/blood recipient 200 152 (76.0) 13,542 9,342 (69.0) 13,860 9,547 (68.9)
Victim of sexual assault 108 82 (75.9) 20,818 14,423 (69.3) 21,103 14,580 (69.1)
Health care exposure 127 96 (75.6) 23,463 17,459 (74.4) 23,780 17,666 (74.3)
No acknowledged risk 1,648 991 (60.1) 161,540 90,252 (55.9) 165,386 92,425 (55.9)
Heterosexual no other risk 4,968 3,604 (72.5) 736,220 467,975 (63.6) 748,756 473,673 (63.3)
Other 266 191 (71.8) 26,307 18,516 (70.4) 26,726 18,764 (70.2)
Not specified 792 253 (31.9) 37,427 11,935 (31.9) 38,578 12,241 (31.7)
Total 35,590 26,465 (74.4) 2,151,669 1,442,847 (67.1) 2,206,794 1,476,564 (66.9)
Positive Negative All Tests
No. of Posttest No. of Posttest No. of Posttest
tests No. (%) tests No. (%) tests No. (%)
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Table 4b(2). HIV tests and posttest counseling by result for insurance status, site type,
type of test, and previous test, publicly funded sites, 1996
Client Record Data
No insurance 13,007 9,699 (74.6) 721,162 470,467 (65.2) 742,326 483,246 (65.1)
Self-insured 1,159 976 (84.2) 103,613 80,117 (77.3) 106,200 81,629 (76.9)
Public assistance 5,523 4,407 (79.8) 231,529 165,091 (71.3) 242,596 171,298 (70.6)
Military/VA 64 52 (81.3) 5,147 3,844 (74.7) 5,246 3,911 (74.6)
Employer insured 2,129 1,826 (85.8) 210,089 174,459 (83.0) 213,716 177,038 (82.8)
Not specified 13,708 9,505 (69.3) 880,129 548,869 (62.4) 896,710 559,442 (62.4)
Total 35,590 26,465 (74.4) 2,151,669 1,442,847 (67.1) 2,206,794 1,476,564 (66.9)
HIV CTS 11,534 9,451 (81.9) 659,643 551,197 (83.6) 674,435 562,238 (83.4)
STD 8,454 5,982 (70.8) 557,461 282,805 (50.7) 570,014 289,853 (50.9)
Drug treatment 2,714 1,999 (73.7) 101,699 72,111 (70.9) 105,624 74,685 (70.7)
Family planning 777 636 (81.9) 242,499 149,216 (61.5) 245,074 150,776 (61.5)
Prenatal/OB 1,528 1,177 (77.0) 166,218 109,101 (65.6) 172,628 111,713 (64.7)
TB 356 266 (74.7) 17,901 9,545 (53.3) 18,377 9,865 (53.7)
CHC/PHC 3,329 2,259 (67.9) 156,553 97,982 (62.6) 161,675 101,167 (62.6)
Prison/jail 2,622 2,058 (78.5) 79,977 62,569 (78.2) 83,310 64,781 (77.8)
Hospital/private MD 1,010 504 (49.9) 23,596 12,596 (53.4) 25,330 13,226 (52.2)
Field visit 1,125 700 (62.2) 42,468 28,641 (67.4) 44,134 29,576 (67.0)
Other 2,081 1,414 (67.9) 100,426 65,378 (65.1) 102,881 66,947 (65.1)
Not specified 60 19 (31.7) 3,228 1,706 (52.9) 3,312 1,737 (52.4)
Total 35,590 26,465 (74.4) 2,151,669 1,442,847 (67.1) 2,206,794 1,476,564 (66.9)
Anonymous 9,547 7,310 (76.6) 621,237 516,596 (83.2) 634,913 525,815 (82.8)
Confidential 25,507 18,811 (73.7) 1,457,569 883,264 (60.6) 1,498,075 907,288 (60.6)
Not specified 536 344 (64.2) 72,863 42,987 (59.0) 73,806 43,461 (58.9)
Total 35,590 26,465 (74.4) 2,151,669 1,442,847 (67.1) 2,206,794 1,476,564 (66.9)
No previous test 10,246 8,019 (78.3) 894,227 628,610 (70.3) 913,655 640,001 (70.0)
Previously negative 9,329 7,283 (78.1) 1,003,110 710,433 (70.8) 1,020,509 720,660 (70.6)
Previously positive 11,476 8,616 (75.1) 3,159 2,085 (66.0) 14,886 10,788 (72.5)
Previously inconclusive 404 333 (82.4) 3,312 2,486 (75.1) 4,570 3,341 (73.1)
Previously unknown 1,792 1,264 (70.5) 69,211 30,136 (43.5) 71,658 31,578 (44.1)
Not specified 2,343 950 (40.5) 178,650 69,097 (38.7) 181,516 70,196 (38.7)
Total 35,590 26,465 (74.4) 2,151,669 1,442,847 (67.1) 2,206,794 1,476,564 (66.9)
Note: Not all project areas report data on insurance status, test type, or previous test history.
Positive Negative All Tests
No. of Posttest No. of Posttest No. of Posttest
tests No. (%) tests No. (%) tests No. (%)
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Table 5. HIV tests by region and project area, publicly funded sites, 1996
U.S. total
Note: Project areas include all 50 states, 6 large cities, the District of Columbia, and 8 other areas. This table excludes American Samoa,
Micronesia, N. Mariana Islands, Marshall Islands, and Palau, which reported no data in 1996.
Number of tests and positive tests for each project area may not represent activity for the entire reporting period.
No. of Positive tests      % of         % of     % of total
tests No. (%)  total tests  total positive U.S. population
Region Northeast
Connecticut 28,110 657 (2.3) (1.1) (1.7) (1.3)
Maine 4,368 30 (0.7) (0.2) (<.1) (0.5)
Massachusetts 50,495 904 (1.8) (1.9) (2.3) (2.4)
New Hampshire 4,917 31 (0.6) (0.2) (<.1) (0.4)
New Jersey 69,290 2,124 (3.1) (2.6) (5.4) (3.1)
New York 131,591 3,246 (2.5) (5.0) (8.3) (7.2)
Pennsylvania 49,832 658 (1.3) (1.9) (1.7) (4.8)
Rhode Island 4,434 35 (0.8) (0.2) (<.1) (0.4)
Vermont 1,239 11 (0.9) (<.1) (<.1) (0.2)
New York City 39,435 1,315 (3.3) (1.5) (3.4) (2.9)
Philadelphia 24,172 697 (2.9) (0.9) (1.8) (0.6)
Region Midwest
Illinois 52,295 429 (0.8) (2.0) (1.1) (4.6)
Indiana 29,200 322 (1.1) (1.1) (0.8) (2.2)
Iowa 14,986 74 (0.5) (0.6) (0.2) (1.1)
Kansas 15,537 52 (0.3) (0.6) (0.1) (1.0)
Michigan 67,285 683 (1.0) (2.6) (1.7) (3.7)
Minnesota 13,323 86 (0.6) (0.5) (0.2) (1.8)
Missouri 34,283 262 (0.8) (1.3) (0.7) (2.1)
Nebraska 6,612 32 (0.5) (0.3) (<.1) (0.6)
North Dakota 2,039 6 (0.3) (<.1) (<.1) (0.3)
Ohio 54,425 527 (1.0) (2.1) (1.3) (4.4)
South Dakota 4,124 26 (0.6) (0.2) (<.1) (0.3)
Wisconsin 23,917 148 (0.6) (0.9) (0.4) (2.0)
Chicago 23,346 309 (1.3) (0.9) (0.8) (1.2)
Region South
Alabama 106,738 740 (0.7) (4.1) (1.9) (1.6)
Arkansas 78,743 386 (0.5) (3.0) (1.0) (0.9)
Delaware 10,184 128 (1.3) (0.4) (0.3) (0.3)
District of Columbia 14,424 517 (3.6) (0.5) (1.3) (0.2)
Florida 249,768 5,329 (2.1) (9.5) (13.6) (5.2)
Georgia 80,874 1,924 (2.4) (3.1) (4.9) (2.6)
Kentucky 24,945 163 (0.7) (1.0) (0.4) (1.5)
Louisiana 70,626 1,074 (1.5) (2.7) (2.7) (1.7)
Maryland 65,003 1,230 (1.9) (2.5) (3.1) (1.9)
Mississippi 85,626 883 (1.0) (3.3) (2.3) (1.0)
North Carolina 112,869 976 (0.9) (4.3) (2.5) (2.7)
Oklahoma 16,928 132 (0.8) (0.6) (0.3) (1.3)
South Carolina 38,085 852 (2.2) (1.5) (2.2) (1.4)
Tennessee 46,538 536 (1.2) (1.8) (1.4) (2.0)
Texas 132,761 1,625 (1.2) (5.1) (4.2) (6.8)
Virginia 83,943 509 (0.6) (3.2) (1.3) (2.5)
West Virginia 9,036 69 (0.8) (0.3) (0.2) (0.7)
Houston 29,087 811 (2.8) (1.1) (2.1) (1.1)
Region West
Alaska 8,235 28 (0.3) (0.3) (<.1) (0.2)
Arizona 26,002 383 (1.5) (1.0) (1.0) (1.5)
California 208,284 1,893 (0.9) (7.9) (4.8) (12.0)
Colorado 31,225 491 (1.6) (1.2) (1.3) (1.3)
Hawaii 13,230 64 (0.5) (0.5) (0.2) (0.4)
Idaho 16,128 75 (0.5) (0.6) (0.2) (0.4)
Montana 15,923 42 (0.3) (0.6) (0.1) (0.3)
Nevada 24,690 236 (1.0) (0.9) (0.6) (0.5)
New Mexico 21,331 153 (0.7) (0.8) (0.4) (0.6)
Oregon 24,725 264 (1.1) (0.9) (0.7) (1.1)
Utah 8,446 78 (0.9) (0.3) (0.2) (0.7)
Washington 43,292 394 (0.9) (1.6) (1.0) (2.0)
Wyoming 7,827 14 (0.2) (0.3) (<.1) (0.2)
San Francisco 25,036 1,168 (4.7) (1.0) (3.0) (0.3)
Los Angeles 78,094 1,302 (1.7) (3.0) (3.3) (3.3)
Region Puerto Rico and Territories
Guam 1,178 3 (0.3) (<.1) (<.1) (<.1)
Puerto Rico 63,584 1,961 (3.1) (2.4) (5.0) (1.3)
U.S. Virgin Islands 1,210 22 (1.8) (<.1) (<.1) (<.1)
Total 2,623,873 39,119 (1.5) (100.0) (100.0) (100.0)
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Table 6. HIV tests by project arearanked by percent positive, publicly funded sites,1996
U.S. total
Rank       Project area      Tests   Percent positive
  1 San Francisco 25,036 (4.7)
  2 District of Columbia 14,424 (3.6)
  3 New York City 39,435 (3.3)
  4 Puerto Rico 63,584 (3.1)
  5 New Jersey 69,290 (3.1)
  6 Philadelphia 24,172 (2.9)
  7 Houston 29,087 (2.8)
  8 New York 131,591 (2.5)
  9 Georgia 80,874 (2.4)
10 Connecticut 28,110 (2.3)
11 * South Carolina 38,085 (2.2)
12 Florida 249,768 (2.1)
13 Maryland 65,003 (1.9)
14 U.S. Virgin Islands 1,210 (1.8)
15 Massachusetts 50,495 (1.8)
16 Los Angeles 78,094 (1.7)
17 Colorado 31,225 (1.6)
18 Louisiana 70,626 (1.5)
20 Arizona 26,002 (1.5)
21 Chicago 23,346 (1.3)
22 Pennsylvania 49,832 (1.3)
23 Delaware 10,184 (1.3)
24 Texas 132,761 (1.2)
25 Tennessee 46,538 (1.2)
26 Indiana 29,200 (1.1)
27 Oregon 24,725 (1.1)
28 *  Mississippi 85,626 (1.0)
29 Michigan 67,285 (1.0)
30 Ohio 54,425 (1.0)
31 Nevada 24,690 (1.0)
32 Utah 8,446 (0.9)
33 = Washington 43,292 (0.9)
34 California 208,284 (0.9)
35 Vermont 1,239 (0.9)
36 North Carolina 112,869 (0.9)
37 Illinois 52,295 (0.8)
38 Rhode Island 4,434 (0.8)
39 Oklahoma 16,928 (0.8)
40 Missouri 34,283 (0.8)
41 * West Virginia 9,036 (0.8)
42 New Mexico 21,331 (0.7)
43 * Alabama 106,738 (0.7)
44 * Maine 4,368 (0.7)
45 Kentucky 24,945 (0.7)
46 Minnesota 13,323 (0.6)
47 * New Hampshire 4,917 (0.6)
48 * South Dakota 4,124 (0.6)
49 Wisconsin 23,917 (0.6)
50 Virginia 83,943 (0.6)
51 * Iowa 14,986 (0.5)
52 * Arkansas 78,743 (0.5)
53 Nebraska 6,612 (0.5)
54 * Hawaii 13,230 (0.5)
55 Idaho 16,128 (0.5)
56 * Alaska 8,235 (0.3)
57 * Kansas 15,537 (0.3)
58 * North Dakota 2,039 (0.3)
59 Montana 15,923 (0.3)
60 * Guam 1,178 (0.3)
61 * Wyoming 7,827 (0.2)
Total 2,623,873 (1.5)
* Indicates Summary Record data; all others report Client Record data.
= Washington reports Client Record data, except for Seattle.
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Table 7. HIV tests and percentage of positive results by project area,
publicly funded sites, 1992-1996
U.S. total
Tests (Percent positive)
1992 1993 1994 1995 1996
Project areas No. (%) No. (%) No. (%) No. (%) No. (%)
Note: Project areas include all 50 states, 6 large cities, the District of Columbia, and 8 other areas. This table excludes
Micronesia, N. Mariana Islands, and Marshall Islands, which reported no data from 1992-1996.
Number of tests and positive tests for each project area may not represent activity for the entire reporting period.
Alabama 13,460 (3.2) 80,669 (0.9) 84,994 (0.9) 101,895 (0.7) 106,738 (0.7)
Alaska 10,324 (0.9) 9,339 (0.3) 8,920 (0.3) 7,850 (0.5) 8,235 (0.3)
Arizona 22,506 (1.7) 24,012 (1.5) 22,801 (1.2) 21,759 (1.2) 26,002 (1.5)
Arkansas 47,444 (0.6) 57,169 (0.6) 59,872 (0.5) 69,002 (0.5) 78,743 (0.5)
California 307,997 (1.3) 237,371 (1.1) 201,890 (1.1) 211,909 (0.9) 208,284 (0.9)
Colorado 44,275 (1.6) 32,177 (2.4) 30,998 (2.2) 32,668 (2.0) 31,225 (1.6)
Connecticut 24,701 (3.4) 22,398 (3.1) 24,594 (3.0) 26,459 (2.7) 28,110 (2.3)
Delaware 10,726 (1.5) 9,684 (1.3) 9,585 (1.5) 9,548 (1.5) 10,184 (1.3)
District of Columbia 21,308 (4.2) 23,044 (4.3) 20,555 (4.2) 17,156 (3.8) 14,424 (3.6)
Florida 210,412 (3.0) 223,121 (2.9) 239,229 (2.7) 231,898 (2.4) 249,768 (2.1)
Georgia 86,011 (2.0) 80,684 (2.0) 89,887 (2.5) 89,676 (2.6) 80,874 (2.4)
Hawaii 19,151 (0.9) 15,776 (0.8) 13,732 (0.5) 13,737 (0.6) 13,230 (0.5)
Idaho 8,376 (0.5) 9,153 (0.5) 3,803 (0.9) 14,690 (0.4) 16,128 (0.5)
Illinois 35,216 (0.8) 32,627 (0.8) 40,236 (0.9) 51,301 (1.0) 52,295 (0.8)
Indiana 24,922 (1.4) 27,691 (1.3) 28,672 (1.2) 32,499 (1.4) 29,200 (1.1)
Iowa 15,588 (0.8) 10,375 (0.5) 12,519 (0.6) 3,675 (0.6) 14,986 (0.5)
Kansas 22,384 (0.5) 18,373 (0.7) 14,744 (0.6) 15,713 (0.4) 15,537 (0.3)
Kentucky 20,801 (0.9) 20,729 (0.9) 20,453 (0.7) 23,681 (0.6) 24,945 (0.7)
Louisiana 59,688 (1.5) 59,799 (1.4) 69,886 (1.7) 65,384 (1.5) 70,626 (1.5)
Maine 6,572 (0.6) 5,560 (0.4) 4,829 (0.4) 4,573 (0.3) 4,368 (0.7)
Maryland 59,251 (1.9) 45,331 (1.0) 43,953 (1.2) 47,931 (2.1) 65,003 (1.9)
Massachusetts 33,747 (2.8) 35,349 (2.5) 41,827 (2.2) 46,931 (2.0) 50,495 (1.8)
Michigan 66,093 (1.3) 64,527 (1.1) 58,884 (1.1) 64,188 (1.0) 67,285 (1.0)
Minnesota 17,700 (1.1) 14,917 (1.0) 14,713 (1.0) 15,461 (0.9) 13,323 (0.6)
Mississippi 68,856 (1.0) 62,834 (1.0) 69,493 (1.1) 76,840 (1.0) 85,626 (1.0)
Missouri 65,593 (1.0) 52,550 (1.0) 43,166 (1.0) 43,811 (0.8) 34,283 (0.8)
Montana 12,254 (0.5) 11,225 (0.4) 10,688 (0.3) 12,043 (0.2) 15,923 (0.3)
Nebraska 6,405 (0.8) 5,731 (1.2) 5,244 (1.0) 5,751 (0.7) 6,612 (0.5)
Nevada 16,972 (1.8) 15,759 (1.6) 15,771 (1.8) 22,061 (1.2) 24,690 (1.0)
New Hampshire 5,707 (0.7) 4,760 (0.6) 4,709 (0.8) 4,862 (0.5) 4,917 (0.6)
New Jersey 79,125 (3.6) 72,709 (3.6) 71,199 (3.5) 69,744 (3.4) 69,290 (3.1)
New Mexico 21,788 (0.7) 22,127 (0.7) 20,692 (0.6) 11,948 (0.6) 21,331 (0.7)
New York 284,227 (3.0) 159,483 (2.9) 57,498 (3.7) 80,835 (3.3) 131,591 (2.5)
North Carolina 78,319 (1.4) 84,990 (1.2) 94,435 (1.2) 105,945 (0.9) 112,869 (0.9)
North Dakota 8,139 (0.3) 1,851 (0.2) 2,067 (0.5) 1,667 (0.1) 2,039 (0.3)
Ohio 60,138 (1.2) 55,038 (1.3) 50,190 (1.2) 52,205 (1.1) 54,425 (1.0)
Oklahoma 21,194 (2.2) 18,692 (1.8) 17,394 (1.7) 16,377 (1.0) 16,928 (0.8)
Oregon 30,202 (1.9) 26,720 (1.8) 22,988 (1.4) 21,004 (1.0) 24,725 (1.1)
Pennsylvania 50,561 (1.4) 39,966 (1.4) 40,333 (1.6) 47,714 (1.5) 49,832 (1.3)
Rhode Island 15,238 (0.5) 12,703 (1.0) 5,326 (0.8) 3,578 (0.5) 4,434 (0.8)
South Carolina 60,755 (2.6) 53,328 (2.6) 44,884 (2.0) 39,327 (2.2) 38,085 (2.2)
South Dakota 4,862 (0.3) 2,424 (0.5) 3,867 (0.6) 1,619 (0.2) 4,124 (0.6)
Tennessee 43,061 (1.8) 42,098 (1.4) 39,277 (1.4) 42,909 (1.4) 46,538 (1.2)
Texas 142,586 (1.4) 142,633 (1.4) 147,749 (1.4) 148,667 (1.3) 132,761 (1.2)
Utah 8,414 (1.4) 6,830 (1.0) 7,345 (1.1) 7,926 (0.4) 8,446 (0.9)
Vermont 2,025 (0.8) 2,134 (0.4) 1,606 (0.5) 0 (0.0) 1,239 (0.9)
Virginia 88,165 (0.8) 93,634 (0.8) 90,638 (0.7) 84,891 (0.6) 83,943 (0.6)
Washington 49,876 (1.2) 45,626 (1.1) 43,015 (1.1) 44,301 (0.9) 43,292 (0.9)
West Virginia 8,244 (0.9) 7,523 (0.9) 7,381 (0.9) 8,586 (1.0) 9,036 (0.8)
Wisconsin 19,250 (0.6) 19,446 (0.8) 18,234 (0.8) 21,780 (0.6) 23,917 (0.6)
Wyoming 7,777 (0.2) 6,590 (0.2) 6,464 (0.3) 6,606 (0.2) 7,827 (0.2)
Samoa 255 (0.0) 115 (0.0) 115 (0.0) 5 (0.0) 0 (0.0)
Palau 988 (0.0) 470 (0.2) 860 (0.0) 247 (0.0) 0 (0.0)
Guam 1,638 (0.2) 2,055 (0.3) 2,567 (0.1) 1,748 (0.4) 1,178 (0.3)
Puerto Rico 50,650 (6.1) 71,747 (4.8) 76,435 (3.7) 71,463 (3.5) 63,584 (3.1)
U.S. Virgin Islands 0 (0.0) 0 (0.0) 1,305 (2.1) 573 (3.5) 1,210 (1.8)
San Francisco 28,304 (5.8) 24,893 (6.6) 33,729 (5.1) 19,729 (4.2) 25,036 (4.7)
Los Angeles 25,779 (1.3) 61,187 (1.9) 55,193 (1.8) 72,070 (1.7) 78,094 (1.7)
New York City 46,564 (6.4) 45,467 (5.6) 39,967 (4.2) 40,020 (3.9) 39,435 (3.3)
Houston 34,420 (2.9) 31,730 (2.9) 27,482 (2.8) 29,564 (2.5) 29,087 (2.8)
Chicago 20,863 (2.6) 24,843 (1.8) 30,795 (1.6) 27,819 (1.5) 23,346 (1.3)
Philadelphia 31,209 (3.6) 32,037 (3.2) 27,852 (3.2) 25,615 (3.0) 24,172 (2.9)
Total 2,689,056 (2.0) 2,523,823 (1.9) 2,399,529 (1.8) 2,491,434 (1.6) 2,623,873 (1.5)
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Table 8. HIV tests and percent posttest counseled, posttest negative, and posttest
positive by project area, ranked according to percent posttest counseled,
publicly funded sites, 1996
Client Record Data
            Percent           Percent posttest    Percent posttest
    No. of             posttest                 counseled         counseled
Rank         Project area     tests           counseled             negative result             positive result
  1 Connecticut 28,110 87.4 87.4 92.4
  2 Nebraska 6,612 86.4 86.5 90.6
  3 Utah 8,446 86.3 86.3 94.9
  4 Washington 22,121 85.8 85.8 86.6
  5 Arizona 26,002 84.1 84.1 87.5
  6 Wisconsin 23,917 83.7 83.7 91.2
  7 Pennsylvania 49,832 83.2 83.4 84.2
  8 California 208,284 81.6 81.7 76.7
  9 Puerto Rico 63,584 81.5 82.3 84.4
10 Massachusetts 50,495 81.2 81.3 74.7
11 New York City 39,435 81.1 81.1 83.2
12 Minnesota 13,323 80.7 80.8 87.2
13 New York 131,591 78.3 80.5 80.1
14 New Mexico 21,331 75.6 77.1 92.8
15 Texas 132,761 74.0 74.1 88.7
16 Nevada 24,690 73.9 73.9 77.1
17 San Francisco 25,036 73.7 74.2 65.5
18 Los Angeles 78,094 73.6 73.7 71.0
19 Ohio 54,425 73.2 73.3 79.5
20 Rhode Island 4,434 72.1 72.3 88.6
21 Indiana 29,200 71.7 71.9 86.3
22 New Jersey 69,290 71.2 71.1 77.1
23 Delaware 10,184 70.7 70.7 78.1
24 Oklahoma 16,928 70.5 70.6 77.3
25 Colorado 31,225 70.1 70.7 31.2
26 Illinois 52,295 68.3 68.7 73.0
27 District of Columbia 14,424 67.7 69.0 71.4
28 Michigan 67,285 67.7 67.9 81.6
29 U.S. Virgin Islands 1,210 66.4 67.9 77.3
30 Philadelphia 24,172 65.9 65.5 74.2
31 Kentucky 24,945 65.7 66.3 81.0
32 Maryland 65,003 65.3 65.3 72.8
33 Oregon 24,725 62.5 62.5 59.8
34 North Carolina 112,869 61.2 61.2 67.7
35 Tennessee 46,538 59.5 59.2 94.2
36 Florida 249,768 59.0 58.8 69.4
37 Chicago 23,346 56.5 57.8 74.8
38 Houston 29,087 56.0 55.6 72.9
39 Georgia 80,874 49.9 49.6 74.7
40 Louisiana 70,626 38.7 38.9 39.1
41 Virginia 83,943 32.3 32.2 47.9
42 *Missouri 34,283 30.1 29.9 51.1
43 = Montana 15,923 28.0 27.9 28.6
44 = Idaho 16,128 0.0 0.0 0.0
Total 2,206,794 66.9 67.1 74.4
* Missouri does not receive posttest counseling data from STD sites, resulting in lower overall return rates.
= Montana and Idaho have laboratory-based data collection systems and are unable to provide complete posttest counseling information
at this time.
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Table 9. HIV tests and percent posttest counseled, posttest negative, and posttest
positive by project area, ranked according to percent posttest positive,
publicly funded sites, 1996
Client Record Data
             Percent             Percent posttest         Percent posttest
  No. of              posttest                  counseled          counseled
Rank            Project area   tests            counseled              negative result            positive result
  1 Utah 8,446 86.3 86.3 94.9
  2 Tennessee 46,538 59.5 59.2 94.2
  3 New Mexico 21,331 75.6 77.1 92.8
  4 Connecticut 28,110 87.4 87.4 92.4
  5 Wisconsin 23,917 83.7 83.7 91.2
  6 Nebraska 6,612 86.4 86.5 90.6
  7 Texas 132,761 74.0 74.1 88.7
  8 Rhode Island 4,434 72.1 72.3 88.6
  9 Arizona 26,002 84.1 84.1 87.5
10 Minnesota 13,323 80.7 80.8 87.2
11 Washington 22,121 85.8 85.8 86.6
12 Indiana 29,200 71.7 71.9 86.3
13 Puerto Rico 63,584 81.5 82.3 84.4
14 Pennsylvania 49,832 83.2 83.4 84.2
15 New York City 39,435 81.1 81.1 83.2
16 Michigan 67,285 67.7 67.9 81.6
17 Kentucky 24,945 65.7 66.3 81.0
18 New York 131,591 78.3 80.5 80.1
19 Ohio 54,425 73.2 73.3 79.5
20 Delaware 10,184 70.7 70.7 78.1
21 Oklahoma 16,928 70.5 70.6 77.3
22 U.S. Virgin Islands 1,210 66.4 67.9 77.3
23 Nevada 24,690 73.9 73.9 77.1
24 New Jersey 69,290 71.2 71.1 77.1
25 California 208,284 81.6 81.7 76.7
26 Chicago 23,346 56.5 57.8 74.8
27 Georgia 80,874 49.9 49.6 74.7
28 Massachusetts 50,495 81.2 81.3 74.7
29 Philadelphia 24,172 65.9 65.5 74.2
30 Illinois 52,295 68.3 68.7 73.0
31 Houston 29,087 56.0 55.6 72.9
32 Maryland 65,003 65.3 65.3 72.8
33 District of Columbia 14,424 67.7 69.0 71.4
34 Los Angeles 78,094 73.6 73.7 71.0
35 Florida 249,768 59.0 58.8 69.4
36 North Carolina 112,869 61.2 61.2 67.7
37 San Francisco 25,036 73.7 74.2 65.5
38 Oregon 24,725 62.5 62.5 59.8
39 * Missouri 34,283 30.1 29.9 51.1
40 Virginia 83,943 32.3 32.2 47.9
41 Louisiana 70,626 38.7 38.9 39.1
42 Colorado 31,225 70.1 70.7 31.2
43 = Montana 15,923 28.0 27.9 28.6
44 = Idaho 16,128 0.0 0.0 0.0
Total 2,206,794 66.9 67.1 74.4
* Missouri does not receive posttest counseling data from STD sites, resulting in lower overall return rates.




Funds for CT are provided to states and local health
departments as part of funding for a comprehensive HIV
prevention program. In 1996, 65 project areas were funded
by CDC to provide HIV CT. These areas were the 50
states, 6 cities (Chicago, Houston, Los Angeles, New York,
Philadelphia, and San Francisco), District of Columbia,
the commonwealths of Puerto Rico and the Northern
Mariana Islands, 3 territories (American Samoa, Guam,
and the U.S. Virgin Islands), the Republic of the Marshall
Islands, the Republic of Palau, and the Federated States
of Micronesia.
Testing Sites
HIV CT services are provided in a variety of settings,
including freestanding HIV CT sites (which offer
anonymous tests or confidential tests or both), STD clinics,
family planning clinics, prenatal clinics, drug treatment
centers, and correctional facilities.  Testing sites included
in this report are required to provide pretest and posttest
counseling services. The number of facilities providing
publicly funded HIV-antibody counseling and testing
services has expanded from 5,149 sites in 1989 to 9,691
sites in 1996.
Test sites that are reported as community health centers
(CHC) or public health clinics (PHC) by client record
reporting project areas and test sites reported as other
health department site from summary record reporting
project areas are all referred to as other health
department sites in this document.
Non-CDC Funding of Testing
Not reported through this system are HIV tests funded by
federal agencies other than CDC, including the
Departments of Defense, Justice, Labor, and Veterans
Affairs; the Health Care Financing Administration; and
agencies of the Public Health Service other than CDC.
Health departments also use state and local funds to
support HIV CT services.
Data Collection
The national collection of detailed data on persons receiving
HIV CT began as a pilot project in 1988 and was
implemented formally in 1989. HIV test results and other
data from publicly funded testing are reported to CDC
through the Counseling and Testing System.
Data collection typically takes place in three steps. First,
the counselor or clinician who provides pretest counseling
records the demographic and HIV risk information on a
standardized data collection form. Next, laboratory test
results are recorded. Finally, data are added or emended
on the basis of information collected during posttest
counseling.
Data are sent to CDC by each project area in one of two
formats: line-listed data on individual tests (client record)
or reports of data that have been aggregated locally
(summary record). Over time, areas have increasingly
adopted the client record format, which provides more
details. In 1996, the results of 2,620,283 tests were reported
to CDC in the client record format; 84% of all tests and
91% of positive tests from 44 areas were in client record
format (includes Washington State other than Seattle,
which reports in summary record format). Data reported
in the client record format are aggregated and combined
with summary record reports to provide U.S. totals. Tables
and figures in this report with U.S. total in the title include
both summary record and client record data.
Data Tables
Several project areas do not report data for all variables
on each test (i.e., risk behaviors, sex, age, and race/
ethnicity). For this reason, when test results are reported
in summary record tables, the totals in the various
categories are not necessarily equal.
There are several tables of posttest counseling return
rates. Table 4a is for all tests (U.S. total), and Tables
4b(1) and 4b(2) are for client record test results. Client
record data include separate posttest counseling return
rates for negative and positive test results; summary record
reports do not make this distinction. Posttest return rates
by client record project areas ranked by return rate are
listed in Table 8.  Posttest counseling return rates of those
tests with a positive result are listed in Table 9.
Risk Behavior Categories
HIV counselors record all risk behaviors that an individual
client reports.  Therefore, multiple risk behaviors for a
client may be reported from a single testing episode. For
analysis, a single risk behavior (except for the combination
of a man who has sex with men and uses injection drugs)
is assigned for each testing episode by using a standard
hierarchy. Initially, all records are placed in the Other
category. If no responses are marked (all blanks), the
record is placed in the Not specified category. From
there, depending on the response, the records are moved
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up until the reported risk that is highest on the hierarchy is
reached. This system of assigning risk for analysis is based
on what is believed to be the most likely risk for exposure
to HIV. Because counseling and testing programs cannot
definitively identify the mode of transmission for infected
clients and because transmission has not occurred among
uninfected clients, the distribution of assigned risks should
be interpreted as an estimate. The hierarchical assigning
of risk does not limit counseling, which typically includes
efforts to help reduce all risk behaviors.
Anonymous and Confidential Testing
Persons who choose anonymous HIV testing are not
required to provide their names; confidential testing
requires that clients provide their names.
As of May 1997, anonymous testing was available in 40
states, the District of Columbia, and Puerto Rico. States
that provide only confidential testing are Alabama, Idaho,
Mississippi, Nevada, North Carolina, North Dakota, South
Carolina, South Dakota, Tennessee, and Wyoming. This
information was obtained by collating information in the
CDC CT database and from surveys of state and local
health department staff and does not necessarily reflect
current laws or regulations about testing.
CDC encourages each state and territory to report changes
in the availability of anonymous and confidential testing to
the Technical Information and Communications Branch
(Mailstop E49), Division of HIV/AIDS Prevention,
National Center for HIV, STD, and TB Prevention, CDC,
Atlanta, GA 30333 (telephone 404-639-2072).
Interpretation of Findings
The HIV Counseling and Testing System contains one
record for each reported HIV counseling and testing
episode2.6 million in 1996 alone. However, because
records contain no individual identifying information, it is
not possible to link the results of repeat tests for the same
person. Therefore, results from this system are
summarized as numbers of HIV CT episodes rather than
numbers of persons tested.
Data from this system can be used to describe HIV
counseling and testing programs, to characterize the
populations who receive services, to guide the development
of HIV prevention programs, and to estimate the need for
early intervention services for persons with HIV infection.
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Errata
The computer programs used to produce Tables 3a and
3b have been changed since the publication of similar
tables in HIV Counseling and Testing in Publicly Funded
Sites, 1995 Summary Report. Specifically, the risks man
who has sex with men and sex partner who is man who
has sex with men were previously considered two
different risks; the current computer program considers
these the same risk. In the 1995 report, records for females
that had invalid data were not deleted. These invalid records
have been deleted. Revised tables for 1995 data for males
and females are in the Appendix.
In 1995, the sole risk reported most often by men was
heterosexual exposure (75%). The two risks most
commonly reported together by men were heterosexual
exposure and history of an STD (19%). The three risks
most commonly reported together by men were
heterosexual exposure, history of an STD, and having a
sex partner at risk for HIV (6%). In each grouping of
single or multiple risks, the highest percentage of positive
test results was for men who reported a sex partner with
HIV or AIDS as one of the risks (8.8%-12.6%).
In 1995, the sole risk reported most often by women was
heterosexual exposure (85%). The two risks most
commonly reported together by women were heterosexual
exposure and having a partner at risk for HIV (25%).
The three risks most commonly reported together by
women were heterosexual exposure, history of an STD,
and having a sex partner at risk for HIV (14%). In each
grouping of single or multiple risks, the highest percentage
of positive test results was for women who reported a
sex partner with HIV or AIDS as one of the risks (8.8%-
14.5%).
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Table 3a. HIV tests and positive results by single and multiple exposure
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Table 3b. HIV tests and positive results by single and multiple exposure
categories, publicly funded sites, 1995 (revised)
C
females,
lient Record Data
3,927
428,802
1,594
453
7,237
62,964
504,977
68
2,451
12
46
53
370
3,000
1.7
0.6
0.8
10.2
0.7
0.6
0.6
2,955
1,125
86,212
70,995
6,660
288
490
174,372
343,097
158
28
547
550
585
0
30
989
2,887
5.3
2.5
0.6
0.8
8.8
0.0
6.1
0.6
0.8
612
152
3,142
823
20,706
3,061
124,147
152,643
22
22
130
90
140
251
1,196
1,851
3.6
14.5
4.1
10.9
0.7
8.2
1.0
1.2
716
262
505
66,331
67,814
23
38
42
1,154
1,257
3.2
14.5
8.3
1.7
1.9
STD
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